Shopping Cart 0
Cart Subtotal
AED 0

Accugenomics Inc-Product Pipeline Analysis, 2017 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 2753

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 5505

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 8258

Details

Summary

Accugenomics Inc (Accugenomics) is a provider of molecular diagnostics for cancer. The company develops and markets gene expression tests to diagnose and monitor cancer treatment. It offers gene expression tests including lung cancer risk test, standardized BCR-ABL molecular diagnostics test and lung cancer diagnostic test. Accugenomics' product candidates include LCDT-AGx-3 Gene lung cancer diagnostic tests that help improve diagnostic precision as an adjunct to morphological criteria and LCCT-AGx-4 Gene lung cancer chemoresistance test to estimate the response of different lung cancers to cisplatin or irinotecan related treatments. The company licensed its intellectual property from the University of Toledo. It operates through its development laboratory located in Wilmington. Accugenomics is headquartered in Wilmington, North Carolina, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Accugenomics Inc

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Accugenomics Inc Company Overview 4

Accugenomics Inc Company Snapshot 4

Accugenomics Inc Pipeline Products and Ongoing Clinical Trials Overview 4

Accugenomics Inc-Pipeline Analysis Overview 7

Accugenomics Inc-Key Facts 7

Accugenomics Inc-Major Products and Services 8

Accugenomics Inc Pipeline Products by Development Stage 9

Accugenomics Inc Ongoing Clinical Trials by Trial Status 11

Accugenomics Inc Pipeline Products Overview 13

AccuKit 13

AccuKit Product Overview 13

Lung Cancer Chemoresistance Test-4 Gene 14

Lung Cancer Chemoresistance Test-4 Gene Product Overview 14

Lung Cancer Diagnostic Test-3 Gene 15

Lung Cancer Diagnostic Test-3 Gene Product Overview 15

Lung Cancer Risk Test-15 Gene Test 16

Lung Cancer Risk Test-15 Gene Test Product Overview 16

Lung Cancer Risk Test-15 Gene Test Clinical Trial 17

Accugenomics Inc-Key Competitors 18

Accugenomics Inc-Key Employees 19

Accugenomics Inc-Locations And Subsidiaries 20

Head Office 20

Recent Developments 21

Accugenomics Inc, Recent Developments 21

Jul 08, 2016: AccuGenomics presents their molecular standardization technology at GTCbio Molecular Diagnostic Conference in Boston, MA. 21

Jan 29, 2016: Release of lung cancer risk test trial details and establishment of biospecimen repository 21

Dec 18, 2015: Progress in Efforts to Develop AccuKit for Monitoring of BCR-ABL Treatment 21

Jul 01, 2015: STARSEQ Demonstrates Measurement of Undetected Errors that Arise in Next Generation Sequencing 22

Jun 11, 2015: SNAQ BCR-ABL Pilot Study Results Presented at 20th Annual European Hematology Association Meeting 22

Sep 07, 2014: Preliminary SNAQ BCR-ABL Pilot results presented at the 16th Annual John Goldman Conference on Chronic Myeloid Leukemia 23

Jul 01, 2014: AccuGenomics awarded United States patent for a molecular test that predicts lung cancer risk 23

Appendix 24

Methodology 24

About GlobalData 26

Contact Us 26

Disclaimer 26


List Of Figure

List of Figures

Accugenomics Inc Pipeline Products by Equipment Type 5

Accugenomics Inc Pipeline Products by Development Stage 9

Accugenomics Inc Ongoing Clinical Trials by Trial Status 11


List Of Table

List of Tables

Accugenomics Inc Pipeline Products and Ongoing Clinical Trials Overview 4

Accugenomics Inc Pipeline Products by Equipment Type 5

Accugenomics Inc Pipeline Products by Indication 6

Accugenomics Inc Ongoing Clinical Trials by Trial Status 6

Accugenomics Inc, Key Facts 7

Accugenomics Inc, Major Products and Services 8

Accugenomics Inc Number of Pipeline Products by Development Stage 9

Accugenomics Inc Pipeline Products Summary by Development Stage 10

Accugenomics Inc Ongoing Clinical Trials by Trial Status 11

Accugenomics Inc Ongoing Clinical Trials Summary 12

AccuKit-Product Status 13

AccuKit-Product Description 13

Lung Cancer Chemoresistance Test-4 Gene-Product Status 14

Lung Cancer Chemoresistance Test-4 Gene-Product Description 14

Lung Cancer Diagnostic Test-3 Gene-Product Status 15

Lung Cancer Diagnostic Test-3 Gene-Product Description 15

Lung Cancer Risk Test-15 Gene Test-Product Status 16

Lung Cancer Risk Test-15 Gene Test-Product Description 16

Lung Cancer Risk Test-15 Gene Test-Validation of a Multi-gene Test for Lung Cancer Risk 17

Accugenomics Inc, Key Employees 19

Glossary 25

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Accugenomics Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

Company Profile

Company Profile Title

Summary

Accugenomics Inc (Accugenomics) is a provider of molecular diagnostics for cancer. The company develops and markets gene expression tests to diagnose and monitor cancer treatment. It offers gene expression tests including lung cancer risk test, standardized BCR-ABL molecular diagnostics test and lung cancer diagnostic test. Accugenomics' product candidates include LCDT-AGx-3 Gene lung cancer diagnostic tests that help improve diagnostic precision as an adjunct to morphological criteria and LCCT-AGx-4 Gene lung cancer chemoresistance test to estimate the response of different lung cancers to cisplatin or irinotecan related treatments. The company licensed its intellectual property from the University of Toledo. It operates through its development laboratory located in Wilmington. Accugenomics is headquartered in Wilmington, North Carolina, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

The report analyzes all pipeline products in development for the company Accugenomics Inc

The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

The report provides detailed description of products in development, technical specification and functions

The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

To formulate effective Research & Development strategies

Develop market-entry and market expansion strategies

Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Accugenomics Inc Company Overview 4

Accugenomics Inc Company Snapshot 4

Accugenomics Inc Pipeline Products and Ongoing Clinical Trials Overview 4

Accugenomics Inc-Pipeline Analysis Overview 7

Accugenomics Inc-Key Facts 7

Accugenomics Inc-Major Products and Services 8

Accugenomics Inc Pipeline Products by Development Stage 9

Accugenomics Inc Ongoing Clinical Trials by Trial Status 11

Accugenomics Inc Pipeline Products Overview 13

AccuKit 13

AccuKit Product Overview 13

Lung Cancer Chemoresistance Test-4 Gene 14

Lung Cancer Chemoresistance Test-4 Gene Product Overview 14

Lung Cancer Diagnostic Test-3 Gene 15

Lung Cancer Diagnostic Test-3 Gene Product Overview 15

Lung Cancer Risk Test-15 Gene Test 16

Lung Cancer Risk Test-15 Gene Test Product Overview 16

Lung Cancer Risk Test-15 Gene Test Clinical Trial 17

Accugenomics Inc-Key Competitors 18

Accugenomics Inc-Key Employees 19

Accugenomics Inc-Locations And Subsidiaries 20

Head Office 20

Recent Developments 21

Accugenomics Inc, Recent Developments 21

Jul 08, 2016: AccuGenomics presents their molecular standardization technology at GTCbio Molecular Diagnostic Conference in Boston, MA. 21

Jan 29, 2016: Release of lung cancer risk test trial details and establishment of biospecimen repository 21

Dec 18, 2015: Progress in Efforts to Develop AccuKit for Monitoring of BCR-ABL Treatment 21

Jul 01, 2015: STARSEQ Demonstrates Measurement of Undetected Errors that Arise in Next Generation Sequencing 22

Jun 11, 2015: SNAQ BCR-ABL Pilot Study Results Presented at 20th Annual European Hematology Association Meeting 22

Sep 07, 2014: Preliminary SNAQ BCR-ABL Pilot results presented at the 16th Annual John Goldman Conference on Chronic Myeloid Leukemia 23

Jul 01, 2014: AccuGenomics awarded United States patent for a molecular test that predicts lung cancer risk 23

Appendix 24

Methodology 24

About GlobalData 26

Contact Us 26

Disclaimer 26


List Of Figure

List of Figures

Accugenomics Inc Pipeline Products by Equipment Type 5

Accugenomics Inc Pipeline Products by Development Stage 9

Accugenomics Inc Ongoing Clinical Trials by Trial Status 11


List Of Table

List of Tables

Accugenomics Inc Pipeline Products and Ongoing Clinical Trials Overview 4

Accugenomics Inc Pipeline Products by Equipment Type 5

Accugenomics Inc Pipeline Products by Indication 6

Accugenomics Inc Ongoing Clinical Trials by Trial Status 6

Accugenomics Inc, Key Facts 7

Accugenomics Inc, Major Products and Services 8

Accugenomics Inc Number of Pipeline Products by Development Stage 9

Accugenomics Inc Pipeline Products Summary by Development Stage 10

Accugenomics Inc Ongoing Clinical Trials by Trial Status 11

Accugenomics Inc Ongoing Clinical Trials Summary 12

AccuKit-Product Status 13

AccuKit-Product Description 13

Lung Cancer Chemoresistance Test-4 Gene-Product Status 14

Lung Cancer Chemoresistance Test-4 Gene-Product Description 14

Lung Cancer Diagnostic Test-3 Gene-Product Status 15

Lung Cancer Diagnostic Test-3 Gene-Product Description 15

Lung Cancer Risk Test-15 Gene Test-Product Status 16

Lung Cancer Risk Test-15 Gene Test-Product Description 16

Lung Cancer Risk Test-15 Gene Test-Validation of a Multi-gene Test for Lung Cancer Risk 17

Accugenomics Inc, Key Employees 19

Glossary 25

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Accugenomics Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies